Search Results
Chemotherapy + Ramucirumab as Second-Line Therapy in mGC
Global Use of Second-Line Therapy in mGC
Metastatic Gastric Cancer: Promising Second-Line Trials
Case presentation and discussion: Second-line therapy in gastric cancer
Dr. Chau on Findings of Ramucirumab Plus Pembrolizumab in Gastric/GEJ Cancer
Second-Line Therapy for Metastatic Colon Cancer
Second-Line Therapy for RAS Wild-Type mCRC
Dr. Venook Discusses the Approval of Ramucirumab Plus Paclitaxel
Ramucirumab efficacy in patients with advanced HCC Speaker: Dr. Kanan Alshammari
Dr. Ilson Discusses the Optimal Adjuvant Therapy for Resectable Gastric Cancer
Dr. Davis on the Potential for Maintenance Therapy in Gastric Cancer
mCRC: Second-Line Treatment Decisions
